Kensington Investment Counsel’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.1M | Buy |
9,100
+9
| +0.1% | +$1.09K | 0.47% | 61 |
|
|
2025
Q1 | $1.01M | Sell |
9,091
-369
| -4% | -$41.1K | 0.45% | 61 |
|
|
2024
Q4 | $921K | Hold |
9,460
| – | – | 0.38% | 70 |
|
|
2024
Q3 | $1.09M | Sell |
9,460
-1
| -0% | -$115 | 0.45% | 67 |
|
|
2024
Q2 | $1.01M | Sell |
9,461
-160
| -2% | -$17K | 0.45% | 66 |
|
|
2024
Q1 | $931K | Sell |
9,621
-187
| -2% | -$18.1K | 0.43% | 69 |
|
|
2023
Q4 | $990K | Buy |
9,808
+458
| +5% | +$46.2K | 0.52% | 63 |
|
|
2023
Q3 | $952K | Sell |
9,350
-957
| -9% | -$97.5K | 0.59% | 61 |
|
|
2023
Q2 | $1.04M | Buy |
10,307
+707
| +7% | +$71.3K | 0.66% | 58 |
|
|
2023
Q1 | $883K | Sell |
9,600
-4,190
| -30% | -$385K | 0.67% | 58 |
|
|
2022
Q4 | $1.25M | Sell |
13,790
-486
| -3% | -$44.1K | 0.98% | 46 |
|
|
2022
Q3 | $1.09M | Buy |
14,276
+691
| +5% | +$52.5K | 0.91% | 52 |
|
|
2022
Q2 | $1.15M | Sell |
13,585
-235
| -2% | -$19.9K | 0.98% | 45 |
|
|
2022
Q1 | $1.21M | Buy |
13,820
+656
| +5% | +$57.6K | 0.8% | 56 |
|
|
2021
Q4 | $1.15M | Buy |
+13,164
| New | +$1.15M | 0.67% | 70 |
|
|
2021
Q2 | $1.19M | Buy |
12,994
+495
| +4% | +$45.2K | 0.81% | 61 |
|
|
2021
Q1 | $1.07M | Buy |
12,499
+1,328
| +12% | +$113K | 0.8% | 62 |
|
|
2020
Q4 | $1.06M | Buy |
+11,171
| New | +$1.06M | 0.87% | 60 |
|